US Stock MarketDetailed Quotes

Cardiff Oncology (CRDF)

Watchlist
  • 1.670
  • -0.060-3.47%
Close May 15 16:00 ET
  • 1.660
  • -0.010-0.60%
Post 20:01 ET
114.18MMarket Cap-2.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cardiff Oncology (CRDF) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-62.39%41K
-13.18%593K
60.93%243K
-27.27%120K
-25.77%121K
-46.83%109K
39.96%683K
-3.21%151K
17.02%165K
50.93%163K
Operating revenue
-62.39%41K
-13.18%593K
60.93%243K
-27.27%120K
-25.77%121K
-46.83%109K
39.96%683K
-3.21%151K
17.02%165K
50.93%163K
Cost of revenue
Gross profit
Operating expense
-11.04%12.89M
0.44%49.55M
-36.57%8.07M
-5.26%12.09M
17.23%14.9M
30.10%14.49M
7.48%49.33M
21.31%12.72M
16.47%12.77M
3.18%12.71M
Selling and administrative expenses
52.62%6.13M
13.96%14.22M
-0.53%3M
24.66%3.9M
3.20%3.32M
28.24%4.01M
-4.30%12.48M
10.50%3.01M
6.36%3.13M
-25.16%3.22M
-Selling and marketing expense
----
----
----
----
----
----
----
----
-25.37%400K
-21.40%459K
-General and administrative expense
52.62%6.13M
13.96%14.22M
-0.53%3M
24.66%3.9M
3.20%3.32M
28.24%4.01M
-4.30%12.48M
10.50%3.01M
6.36%3.13M
-25.16%3.22M
Research and development costs
-35.43%6.77M
-4.13%35.33M
-47.75%5.08M
-14.97%8.2M
21.98%11.58M
30.83%10.48M
12.16%36.85M
25.11%9.71M
20.17%9.64M
18.37%9.49M
Operating profit
10.65%-12.85M
-0.64%-48.96M
37.74%-7.83M
4.98%-11.97M
-17.79%-14.78M
-31.55%-14.38M
-7.13%-48.65M
-21.68%-12.57M
-16.46%-12.6M
-2.76%-12.55M
Net non-operating interest income expense
-46.23%506K
-4.76%3.1M
-22.24%612K
-3.37%716K
3.73%835K
1.62%941K
-19.91%3.26M
-21.92%787K
-30.62%741K
-23.55%805K
Non-operating interest income
-46.23%506K
-4.76%3.1M
-22.24%612K
-3.37%716K
3.73%835K
1.62%941K
-19.91%3.26M
-21.92%787K
-30.62%741K
-23.55%805K
Other net income (expense)
-114.29%-1K
112.82%5K
50.00%-1K
97.37%-1K
275.00%7K
60.20%-39K
84.62%-2K
-76.19%5K
-860.00%-38K
Other non- operating income (expenses)
-114.29%-1K
112.82%5K
50.00%-1K
----
97.37%-1K
275.00%7K
60.20%-39K
84.62%-2K
-76.19%5K
-860.00%-38K
Income before tax
8.11%-12.35M
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
Income tax
Net income
8.11%-12.35M
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
Net income continuous Operations
8.11%-12.35M
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
Minority interest income
Net income attributable to the parent company
8.11%-12.35M
-0.92%-45.85M
38.78%-7.22M
5.04%-11.26M
-18.38%-13.94M
-34.19%-13.43M
-9.63%-45.43M
-26.24%-11.79M
-21.83%-11.86M
-5.63%-11.78M
Preferred stock dividends
0.00%6K
4.17%25K
16.67%7K
0.00%6K
0.00%6K
0.00%6K
0.00%24K
0.00%6K
0.00%6K
0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders
8.10%-12.35M
-0.93%-45.88M
38.75%-7.22M
5.03%-11.26M
-18.37%-13.95M
-34.17%-13.44M
-9.62%-45.46M
-26.22%-11.79M
-21.81%-11.86M
-5.63%-11.78M
Basic earnings per share
10.00%-0.18
27.37%-0.69
47.62%-0.11
32.00%-0.17
19.23%-0.21
9.09%-0.2
-2.15%-0.95
0.00%-0.21
-13.64%-0.25
-4.00%-0.26
Diluted earnings per share
10.00%-0.18
27.37%-0.69
47.62%-0.11
32.00%-0.17
19.23%-0.21
9.09%-0.2
-2.15%-0.95
0.00%-0.21
-13.64%-0.25
-4.00%-0.26
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -62.39%41K-13.18%593K60.93%243K-27.27%120K-25.77%121K-46.83%109K39.96%683K-3.21%151K17.02%165K50.93%163K
Operating revenue -62.39%41K-13.18%593K60.93%243K-27.27%120K-25.77%121K-46.83%109K39.96%683K-3.21%151K17.02%165K50.93%163K
Cost of revenue
Gross profit
Operating expense -11.04%12.89M0.44%49.55M-36.57%8.07M-5.26%12.09M17.23%14.9M30.10%14.49M7.48%49.33M21.31%12.72M16.47%12.77M3.18%12.71M
Selling and administrative expenses 52.62%6.13M13.96%14.22M-0.53%3M24.66%3.9M3.20%3.32M28.24%4.01M-4.30%12.48M10.50%3.01M6.36%3.13M-25.16%3.22M
-Selling and marketing expense ---------------------------------25.37%400K-21.40%459K
-General and administrative expense 52.62%6.13M13.96%14.22M-0.53%3M24.66%3.9M3.20%3.32M28.24%4.01M-4.30%12.48M10.50%3.01M6.36%3.13M-25.16%3.22M
Research and development costs -35.43%6.77M-4.13%35.33M-47.75%5.08M-14.97%8.2M21.98%11.58M30.83%10.48M12.16%36.85M25.11%9.71M20.17%9.64M18.37%9.49M
Operating profit 10.65%-12.85M-0.64%-48.96M37.74%-7.83M4.98%-11.97M-17.79%-14.78M-31.55%-14.38M-7.13%-48.65M-21.68%-12.57M-16.46%-12.6M-2.76%-12.55M
Net non-operating interest income expense -46.23%506K-4.76%3.1M-22.24%612K-3.37%716K3.73%835K1.62%941K-19.91%3.26M-21.92%787K-30.62%741K-23.55%805K
Non-operating interest income -46.23%506K-4.76%3.1M-22.24%612K-3.37%716K3.73%835K1.62%941K-19.91%3.26M-21.92%787K-30.62%741K-23.55%805K
Other net income (expense) -114.29%-1K112.82%5K50.00%-1K97.37%-1K275.00%7K60.20%-39K84.62%-2K-76.19%5K-860.00%-38K
Other non- operating income (expenses) -114.29%-1K112.82%5K50.00%-1K----97.37%-1K275.00%7K60.20%-39K84.62%-2K-76.19%5K-860.00%-38K
Income before tax 8.11%-12.35M-0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M
Income tax
Net income 8.11%-12.35M-0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M
Net income continuous Operations 8.11%-12.35M-0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M
Minority interest income
Net income attributable to the parent company 8.11%-12.35M-0.92%-45.85M38.78%-7.22M5.04%-11.26M-18.38%-13.94M-34.19%-13.43M-9.63%-45.43M-26.24%-11.79M-21.83%-11.86M-5.63%-11.78M
Preferred stock dividends 0.00%6K4.17%25K16.67%7K0.00%6K0.00%6K0.00%6K0.00%24K0.00%6K0.00%6K0.00%6K
Other preferred stock dividends
Net income attributable to common stockholders 8.10%-12.35M-0.93%-45.88M38.75%-7.22M5.03%-11.26M-18.37%-13.95M-34.17%-13.44M-9.62%-45.46M-26.22%-11.79M-21.81%-11.86M-5.63%-11.78M
Basic earnings per share 10.00%-0.1827.37%-0.6947.62%-0.1132.00%-0.1719.23%-0.219.09%-0.2-2.15%-0.950.00%-0.21-13.64%-0.25-4.00%-0.26
Diluted earnings per share 10.00%-0.1827.37%-0.6947.62%-0.1132.00%-0.1719.23%-0.219.09%-0.2-2.15%-0.950.00%-0.21-13.64%-0.25-4.00%-0.26
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -